Biosimilar Monoclonal Antibodies Global Market Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biosimilar Monoclonal Antibodies Global Market Report 2022: By Type, By Application, By Compound” report has been added to ResearchAndMarkets.com’s offering. The global biosimilar monoclonal antibodies market is expected to grow from $4.51 billion in 2021 to $5.47 billion in 2022 at a compound annual growth rate (CAGR) of 21.3%. The market is expected … [Read more…]

Small Molecule Active Pharmaceutical Ingredients (APIs) Contract Manufacturer Quality Benchmarking Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Small Molecule API Contract Manufacturer Quality Benchmarking (7th Edition)” report has been added to ResearchAndMarkets.com’s offering. The Small Molecule API Contract Manufacturing Quality Benchmarking (6th Edition) report brings with it a wealth of knowledge and information created with two goals in mind: to help biopharmaceutical companies make more informed CMO decisions, and to … [Read more…]

Phoenix Canada Oil Company Limited Signs Letter of Intent for Reverse Takeover Transaction with ZYUS Life Sciences Inc.

Not for Distribution to U.S. Newswire Services or for Dissemination in the United States TORONTO–(BUSINESS WIRE)–Phoenix Canada Oil Company Limited (TSX-V: PCO) (“Phoenix“) and ZYUS Life Sciences Inc. (“ZYUS” or the “Company”), a private Canadian life sciences company, together announce that they have entered into a non-binding Letter of Intent dated May 27, 2022 (the … [Read more…]

Global Alzheimers Disease Therapeutics Market 2022-2026: Focus on Cholinesterase Inhibitors & N-methyl-D-aspartate Receptor Antagonists – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Alzheimers Disease Therapeutics Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The alzheimers disease therapeutics market is poised to grow by $3.99 bn during 2022-2026, accelerating at a CAGR of 8.76% The market is driven by the availability, research, and development of novel biomarkers, increasing awareness of Alzheimer’s disease, and a … [Read more…]

The Worldwide Brain Computer Interface Industry Revenue is Expected to Reach $4.4 Billion by 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Brain Computer Interface Market Outlook 2020-2030” report has been added to ResearchAndMarkets.com’s offering. The global brain computer interface (BCI) market is anticipated to grow with a CAGR of 12.54% over the forecast period, i.e., 2021 – 2030. Companies Mentioned NextMind SAS Blackrock Neurotech Advanced Brain Monitoring Inc. NIHON KOHDEN CORPORATION g.tec medical … [Read more…]

New EU Medical Devices Regulations Training: Two Day Virtual Seminar – Essential Tasks to Complete the EU MDR Implementation and Transition (October 12-13, 2022) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The New EU Medical Devices Regulations Training – Essential Tasks to Complete the EU MDR Implementation and Transition” training has been added to ResearchAndMarkets.com’s offering. This 2-day virtual seminar will go into the specifics of the European Union Medical Device Regulation (EU MDR), provide case studies and share lessons learned so your organization … [Read more…]

The Worldwide Refurbished Medical Equipment Industry is Expected to Reach $52.6 Billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Refurbished Medical Equipment Market Research Report by Product, End User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Refurbished Medical Equipment Market size was estimated at USD 29.49 billion in 2021 and expected to reach USD 32.41 billion in 2022. The … [Read more…]

U.S. Food and Drug Administration Approves Two Opdivo® (nivolumab)-Based Regimens as First-Line Treatments for Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Opdivo in combination with chemotherapy and Opdivo plus Yervoy® (ipilimumab) approved based on a Phase 3 trial showing improved overall survival versus chemotherapy alone1,2 Opdivo-based treatments are now approved for five indications in upper gastroesophageal cancers1 PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #CheckMate—Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has … [Read more…]

New CareQuest Institute Report Reveals Growing Link Between Mental Health and Oral Health

In Recognition of Mental Health Awareness Month, Report Highlights Eight Findings on How Depression is Linked to Oral Health BOSTON–(BUSINESS WIRE)–CareQuest Institute for Oral Health® — a leading national nonprofit focused on creating a more accessible, equitable, and integrated oral health system — released a new report during Mental Health Awareness Month that spotlights the … [Read more…]

 Viveon Health Acquisition Corp. Receives Noncompliance Notice Regarding Late Form 10-Q Filing From the NYSE

NEW YORK–(BUSINESS WIRE)–Viveon Health Acquisition Corp. (NYSE: “VHAQU” or the “Company”) announces that on May 24, 2022, as a result of its inability to timely file with the Securities and Exchange Commission (“SEC”) its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2022 (the “Form 10-Q”), it received a notice from … [Read more…]